Data processing: financial – business practice – management – or co – Automated electrical financial or business practice or... – Health care management
Reexamination Certificate
2006-11-20
2010-12-21
O'Connor, Gerald J. (Department: 3686)
Data processing: financial, business practice, management, or co
Automated electrical financial or business practice or...
Health care management
C707S793000
Reexamination Certificate
active
07856362
ABSTRACT:
A system and method for identifying safety concerns regarding a drug identify a first group of patients that have received the drug from a database of healthcare claims and extract one or more medical events that the first group of patients have experienced from the database. The system and method also identify a second group of patients that have received a comparator drug in the database and extract one or more medical events that the second group of patients have experienced. The medical events of the first group are compared to the medical events of the second group to determine at least one common occurrence therebetween. The common occurrence(s) is then filtered based upon one or more user defined outcomes, each including at least one diagnosis, procedure or therapeutic classification; non-medical criteria; and/or patient laboratory test data.
REFERENCES:
patent: 5845255 (1998-12-01), Mayaud
patent: 6219674 (2001-04-01), Classen
patent: 6529892 (2003-03-01), Lambert
patent: 6584472 (2003-06-01), Classen
patent: 7461006 (2008-12-01), Gogolak
patent: 2002/0083080 (2002-06-01), Classen
patent: 2002/0183965 (2002-12-01), Gogolak
patent: 2003/0046110 (2003-03-01), Gogolak
patent: 2005/0079511 (2005-04-01), Mandema et al.
patent: 2006/0111847 (2006-05-01), Pearson et al.
patent: 2006/0195418 (2006-08-01), Classen
patent: 2007/0033075 (2007-02-01), Hoffman et al.
patent: 2310060 (1997-08-01), None
patent: WO 02/088901 (2002-11-01), None
patent: WO 02/089015 (2002-11-01), None
patent: WO 2005/031509 (2005-04-01), None
Walker, Alexander M., “Patterns of Interchange in the Dispensing of Non-Steroidal Anti-Inflammatory Drugs”, J. Clin. Epidemiol. vol. 45, No. 2, pp. 187-195, 1992.
Walker, Alexander M., “Pattern Recognition in Health Insurance Claims Databases”, Parmacoepidemiology and Drug Safety, 2001; 10; 393-397.
Walker, Alexander M., “Postmarketing Follow Up”, JAMA, Nov. 23, 1979—vol. 242, No. 21.
Graham, David J., et al., “Incidence of Hospitalized Rhabdomyolosis in Patients Treated with Lipid-Lowering Drugs” (JAMA, Dec. 1, 2004, vol. 292, No. 21, pp. 2585-2590).
Geraud, G., et al., “Tolerability and safety of frovatripan with short-and long-term use of treatment of migraine and in comparison with sumatripan” ( Headache, Apr. 2002, 42 Suppl. 2:S93-9).
Layton, Deborah, et al. “Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding?” (Eur. J. Clin. Pharmacol. (2001) 57: 167-176).
Smalley, Walter., et al. “Contraindicated Use of Cisapride—Impact of Food and Drug Administration Regulatory Action”, (JAMA, Dec. 20, 2000, vol. 284, No. 23, pp. 3036-3039).
Enger, Cheryl, et al. “Serious ventricular arrhythmias among users of cisapride and other QT-prolonging agents in the United States” (Pharmacoepidemiology and Drug Safety 2002; 11: 477-486.
Dorsey & Whitney LLP
Ingenix Inc.
Nguyen Hiep
O'Connor Gerald J.
LandOfFree
System and method for early identification of safety... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with System and method for early identification of safety..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and System and method for early identification of safety... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4226233